Trial Profile
Safety and efficacy of sofosbuvir-based therapy in HCV-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms ReSCIP
- 05 Jan 2017 New trial record